Pharmacology, clinical pharmacology and potential therapeutic uses of the specific bradycardiac agent alinidine

Eur Heart J. 1985 Sep;6(9):722-9. doi: 10.1093/oxfordjournals.eurheartj.a061932.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / therapeutic use
  • Angina Pectoris / drug therapy
  • Animals
  • Clonidine / adverse effects
  • Clonidine / analogs & derivatives*
  • Clonidine / metabolism
  • Clonidine / pharmacology
  • Clonidine / therapeutic use
  • Coronary Disease / drug therapy
  • Coronary Disease / physiopathology*
  • Drug Evaluation
  • Heart Rate / drug effects*
  • Hemodynamics / drug effects
  • Humans
  • Kinetics
  • Myocardial Infarction / drug therapy
  • Neurocirculatory Asthenia / drug therapy
  • Neuroleptanalgesia
  • Tachycardia / drug therapy
  • Tachycardia / prevention & control

Substances

  • Adrenergic beta-Antagonists
  • alinidine
  • Clonidine